Clinical outcomes of AngioJet pharmacomechanical thrombectomy versus catheter-directed thrombolysis for the treatment of filter-related caval thrombosis

Table 2 Intervention related data between these two groups of patients, n (%)

	CDT group (n = 21)	AngioJet group (n = 44)	χ2/t	P values
Scope of thrombosis
intra-filter thrombosis	18 (85.71)	38 (86.36)	0	1
intra-filter and IVC thrombosis	3 (14.29)	6 (13.64)
Pulmonary embolism	4 (19.05)	8 (18.18)	0	1
Left lung	2 (9.52)	3 (6.82)	–	0.655
Embolism of lobar artery	1 (4.76)	2 (0.45)	–	1
Embolism of segmental artery	3 (14.29)	6 (13.64)	0	1
Median urokinase dosage (million U, range)	1.50 (1.17, 1.83)	0.08 (0.02, 0.25)	-6.495	0
Large-lumen catheter aspiration thrombus	11 (52.38)	33 (75.0)	3.326	0.068
D-Dimer (before intervention)	12.10 (2.29, 30.93)a	8.87 (2.01, 18.88)b	-4.472	0
D-Dimer (after intervention)	8.37 (2.67, 15.98)a	7.14 (0.43, 22.05)b	-3.407	0.001

^aP < 0.01, before treatment vs after treatment in the catheter-directed thrombolysis group.

^bP < 0.01, before treatment vs after treatment in the AngioJet group.

CDT: Catheter-directed thrombolysis; IVC: Inferior vena cava.